{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:42:49Z","timestamp":1792197769232,"version":"4.4.0"},"reference-count":27,"publisher":"The Journal of Rheumatology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>To examine whether a change in the presentation of incident gout happened over the last 20 years and to determine the risk of subsequent gout flares after an initial gout attack.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>All incident cases of gout were identified among residents of Olmsted County, Minnesota, diagnosed in 1989\u20131992 and 2009\u20132010 according to the earliest date fulfilling the 1977 American Rheumatism Association preliminary criteria, or the New York or Rome criteria for gout. Patients in both cohorts were then followed for up to 5 years. Cumulative incidence and person-year methods were used to compare flare rates, and conditional frailty models were used to examine predictors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>A total of 429 patients with incident gout (158 patients in 1989\u20131992 and 271 patients in 2009\u20132010) were identified and followed for a mean of 4.2 years. The majority of patients were male (73%) and the mean age (SD) at gout onset was 59.7 (17.3) years. Classic podagra decreased significantly from 74% to 59% (p &lt; 0.001). Cumulative incidence of first flare was similar in both cohorts (62% vs 60% by 5 yrs in 1989\u20131992 and 2009\u20132010, respectively; p = 0.70), but overall flare rate was marginally higher in 2009\u20132010 compared to 1989\u20131992 (rate ratio: 1.24). Hyperuricemia (HR 1.59) and kidney disease (HR 1.34) were significant predictors of future flares.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>Gout flares were common in both time periods. Hyperuricemia and kidney disease were predictors of future flares in patients with gout. Podagra as a presentation of gout has become relatively less frequent in recent years.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.190346","type":"journal-article","created":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T16:17:54Z","timestamp":1563207474000},"page":"613-618","source":"Crossref","is-referenced-by-count":13,"title":["Changes in the Presentation of Incident Gout and the Risk of Subsequent Flares: A Population-based Study over 20 Years"],"prefix":"10.3899","volume":"47","author":[{"given":"Mohanad M.","family":"Elfishawi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nour","family":"Zleik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoran","family":"Kvrgic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Clement J.","family":"Michet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5847-7475","authenticated-orcid":false,"given":"Cynthia S.","family":"Crowson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Matteson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Bongartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2019,7,15]]},"reference":[{"key":"2021110311500899000_47.4.613.1","doi-asserted-by":"publisher","DOI":"10.1002\/art.30520"},{"key":"2021110311500899000_47.4.613.2","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.170806"},{"key":"2021110311500899000_47.4.613.3","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.91"},{"key":"2021110311500899000_47.4.613.4","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker370"},{"key":"2021110311500899000_47.4.613.5","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-015-0522-8"},{"key":"2021110311500899000_47.4.613.6","doi-asserted-by":"publisher","DOI":"10.1136\/ard.56.1.22"},{"key":"2021110311500899000_47.4.613.7","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.076232"},{"key":"2021110311500899000_47.4.613.8","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwq482"},{"key":"2021110311500899000_47.4.613.9","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780200320"},{"key":"2021110311500899000_47.4.613.10","unstructured":"Ball J Jeffrey MR Kellgren J . The epidemiology of chronic rheumatism; volume 2: atlas of standard radiographs of arthritis. Oxford: Oxford Blackwell Scientific Publications; 1963:295."},{"key":"2021110311500899000_47.4.613.11","unstructured":"Decker JL . Report from the subcommittee on diagnostic criteria for gout. In: Population studies of the rheumatic diseases. Proceedings of the Third International Symposium, New York, June 5\u201310, 1966. Amsterdam: Excerpta Medica Foundation; 1968:457."},{"key":"2021110311500899000_47.4.613.12","doi-asserted-by":"publisher","DOI":"10.1002\/sim.2434"},{"key":"2021110311500899000_47.4.613.13","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209707"},{"key":"2021110311500899000_47.4.613.14","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1093\/rheumatology\/kex250","article-title":"The British Society for Rheumatology guideline for the management of gout","volume":"56","author":"Hui","year":"2017","journal-title":"Rheumatology"},{"key":"2021110311500899000_47.4.613.15","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21773"},{"key":"2021110311500899000_47.4.613.16","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq363"},{"key":"2021110311500899000_47.4.613.17","doi-asserted-by":"publisher","DOI":"10.1002\/art.20405"},{"key":"2021110311500899000_47.4.613.18","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.080487"},{"key":"2021110311500899000_47.4.613.19","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-201254"},{"key":"2021110311500899000_47.4.613.20","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e3181945d2c"},{"key":"2021110311500899000_47.4.613.21","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-009-0022-4"},{"key":"2021110311500899000_47.4.613.22","doi-asserted-by":"publisher","DOI":"10.1002\/art.22474"},{"key":"2021110311500899000_47.4.613.23","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1002\/art.39684","article-title":"A randomized, double-blind, active- and placebo-controlled efficacy and safety study of arhalofenate for reducing flare in patients with gout","volume":"68","author":"Poiley","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2021110311500899000_47.4.613.24","first-page":"61","article-title":"Serum urate levels and gout flares: analysis from managed care data","volume":"12","author":"Sarawate","year":"2006","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"key":"2021110311500899000_47.4.613.25","doi-asserted-by":"publisher","DOI":"10.1002\/art.23177"},{"key":"2021110311500899000_47.4.613.26","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206410"},{"key":"2021110311500899000_47.4.613.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2011.09.033"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.190346","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T18:52:05Z","timestamp":1635965525000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.190346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,15]]},"references-count":27,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4,1]]},"published-print":{"date-parts":[[2020,4]]}},"alternative-id":["10.3899\/jrheum.190346"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.190346","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,15]]}}}